MUCOCUTANEOUS ADVERSE EFFECTS IN PATIENTS UNDERGOING CANCER CHEMOTHERAPY

Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 42

Abstract

BACKGROUND New chemotherapeutic agents and new protocols in oncology have led to an increasing survival rate in patients affected by tumours. Traditional chemotherapy drugs as well as the newer targeted agents are associated with a wide array of cutaneous toxicities.[1] Toxic effects on skin, hair and nails can negatively affect the quality of life and also lead to interruption or discontinuation of these drugs.[2] Aim- To study the various mucocutaneous adverse effects associated with cancer chemotherapy. MATERIALS AND METHODS A total of 200 patients with malignancies undergoing chemotherapy in the oncology ward and outpatient department were screened in this observational study. We have clinically examined 200 patients affected by cancer determining type, treatment and evolution of cutaneous side effects related to chemotherapy. It is a hospital-based observational study. All patients were counselled about the study and informed written consent was obtained. Patients were examined before start of chemotherapy treatment and after every cycle of chemotherapy. Data collected was analysed using SPSS version 16.0. RESULTS In this study, 200 patients including 118 females and 82 males were studied. Majority (56%) of the patients belonged to the age group of 41 - 60 years. The common indications for chemotherapy were carcinoma breast (29%), tongue (11%), buccal mucosa (10%), ovary (8%) and stomach (6%). Among the cutaneous adverse events noted, hair changes were the most common presentation and were reported in 156 (78%) patients. Skin changes were seen in 130 (65%) cases, nail changes in 102 (51%) cases and mucosal changes in 46 (23%) patients. Cisplatin, cyclophosphamide, 5-fluorouracil, carboplatin, paclitaxel and doxorubicin were the most frequently prescribed chemotherapeutic drugs. CONCLUSION Oncological therapies have become more selective and have low systemic toxicity because of their high specificity, but cutaneous side effects are common and may worsen the quality of life of these patients. Our observations necessitate a joint effort between dermatology and oncology for the early recognition and adequate treatment of the cutaneous adverse effects associated with cancer chemotherapy, which may help in reducing morbidity and improving compliance.

Authors and Affiliations

Garima Sharma, P. K. Nigam

Keywords

Related Articles

ROLE OF ULTRASOUND AS AN IMAGING MODALITY IN NEOPLASTIC OVARIAN MASSES IN A TERTIARY CARE HOSPITAL

BACKGROUND Traditionally, the preoperative radiological evaluation of patients suspected of having a uterine or adnexal mass was limited to barium enema examination and excretory urography to find out the mass effect on...

  A STUDY OF 34 CASES OF POTT’S PARAPLEGIA WITH ANTERIOR SPINAL DECOMPRESSION & STABILISATION WITH RIB GRAFT ALONE

 [b] BACKGROUND[/b]: Spinal tuberculosis is mostly secondary to either Pulmonary or Abdominal lesions, and may result in Paraplegia either due to pressure effects of the cold abscess or due to collapse of the vert...

COMPARATIVE STUDY OF THE EFFECT OF CLOMIPHENE CITRATE AND LETROZOLE FOR INDUCTION OF OVULATION IN PRIMARY INFERTILITY

BACKGROUND About 40% cases of infertility are due to failure of ovulation.1 Ovulation has two major components, folliculogenesis and true ovulation.2 Many a protocol has been envisaged using a type of permutation and com...

A METHOD TO IMPROVE IRON COMPLIANCE IN TREATING IRON DEFICIENCY ANAEMIA IN PREGNANCY

BACKGROUND Anaemia among pregnant women is a serious global health concern. Iron deficiency is the most prevalent nutritional deficiency on the globe. In India, pregnant women are amongst the most vulnerable population f...

  A 3 YEAR STUDY OF CARDIAC DISEASE IN PREGNANT WOMEN IN A TERTIARY CARE SET UP

  [b]AIM AND OBJECTIVE[/b]: To analyze pregnant women with heart disease and to assess its influence on feto-maternal outcome. [b]MATERIALS AND METHODS[/b]: The study was carried out during the period of Novemb...

Download PDF file
  • EP ID EP548518
  • DOI 10.14260/jemds/2018/1012
  • Views 83
  • Downloads 0

How To Cite

Garima Sharma, P. K. Nigam (2018). MUCOCUTANEOUS ADVERSE EFFECTS IN PATIENTS UNDERGOING CANCER CHEMOTHERAPY. Journal of Evolution of Medical and Dental Sciences, 7(42), 4535-4538. https://europub.co.uk/articles/-A-548518